GlobalData
GlobalData

Hari Gorla

  • Home
  • Author: Hari Gorla

Australia set to reinforce cancer research with committed funding and research collaborations, says GlobalData

Cancer remains the leading cause of death in Australia. Against this backdrop, the government is supporting the home-grown oncology research with committed funding. Moreover, the research collaborations between the Australian institutes and pharma companies will further help expedite the overall research developments, says GlobalData, a leading data and analytics company. In June 2021, Australia announced […]
Read more

Neos limited presence among UK consumers may be challenging for Sky

Aviva has sold smart home technology provider to Sky, after a successful partnership which modernized the insurer’s home insurance offering and saw it hold the largest market share in that line, according to GlobalData GlobalData’s 2020 UK Insurance Consumer Survey found that only 3.9% of consumers had heard of Neos. This is most likely because […]
Read more

Axsome Therapeutics AXS-05 shows promising results in resistant depression treatment, says GlobalData

Axsome Therapeutics recently announced that its pipeline product AXS-05 (bupropion + dextromethorphan) achieved primary and key secondary endpoints in the MERIT Phase II Trial for the treatment of resistant depression (TRD). A large number of major depressive disorder (MDD) patients do not respond to the available treatments and are referred to as treatment-resistant. There is […]
Read more

UK domestic tourism price increases could see travelers flock to outbound operators in 2022, says GlobalData

Some UK domestic holiday and accommodation providers have increased prices significantly throughout 2021 amid soaring ‘staycation’ demand and this could deter British tourists in 2022, says GlobalData, a leading data and analytics company. Craig Bradley, Associate Travel & Tourism Analyst at GlobalData, comments: “Increasing prices risks resulting in a lost opportunity for many UK tourism […]
Read more

Samsung’s $999 folding phone will establish company’s lead in the foldable phone market, according to GlobalData

Following today’s news (11 August) from the Galaxy Unpacked 2021 event that Samsung announced two new folding phones; Anisha Bhatia, Senior Analyst at GlobalData, a leading data and analytics company, offers her view: “Samsung’s two new folding phones, the Z Fold 3 5G and the Z Flip 3 5G, will firmly establish Samsung’s dominance in this advanced category of […]
Read more

Disappointing setback for Kyowa’s Nouryant in the treatment of Parkinson’s disease in Europe, says GlobalData

While the EMA’s recent recommended rejection of Kyowa Kirin’s Parkinson’s disease (PD) drug Nouryant (istradefylline) may have come as a surprise, key opinion leaders interviewed by leading data and analytics company GlobalData had mixed views on the drug’s efficacy and safety as an add-on therapy. Kyowa Kirin needs to capitalize on Nouryant’s sales in the […]
Read more

Competition for mass affluent individuals is fiercer than ever among providers as digital entrants make their mark, says GlobalData

As the historically paper-based wealth management industry undergoes a long-awaited digital transformation, mass affluent customers are now open to a wider range of providers managing their investments. Traditional players must step up their digital services or lose out on this underserved investor segment, says GlobalData, a leading data and analytics company. Sergel Woldemichael, Wealth Management […]
Read more

Biogen will establish strong presence in multiple sclerosis market through InnoCare Pharma collaboration

Biogen recently announced that it has entered into a license and collaboration agreement with InnoCare Pharma for orelabrutinib, an oral small molecule Bruton’s tyrosine kinase inhibitor (BTKi), for the potential treatment of multiple sclerosis (MS). This new collaboration will enable Biogen to expand its MS pipeline portfolio, while also providing a potential treatment for MS […]
Read more
1 19 20 21 22 23 60